Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$136.25
4.073.08%
At close: -
$136.50
0.250.18%
After Hours: 7:08 PM EDT
Comments
Loading...
Celestica Analyst Ratings and Price Targets | NYSE:CLS | Benzinga
Celestica Inc has a consensus price target of $92.81 based on the ratings of 16 analysts. The high is $150 issued by Stifel on February 19, 2025. The low is $14 issued by Citigroup on January 27, 2023. The 3 most-recent analyst ratings were released by Barclays, BMO Capital, and Argus Research on June 11, 2025, May 22, 2025, and April 29, 2025, respectively. With an average price target of $132 between Barclays, BMO Capital, and Argus Research, there's an implied -3.30% downside for Celestica Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
BMO Capital
Argus Research
RBC Capital
JP Morgan
1calculated from analyst ratings
Analyst Ratings for Celestica
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/11/2025 | Buy Now | 6.96% | Barclays | George Wang71% | $126 → $146 | Maintains | Overweight | Get Alert |
| 05/22/2025 | Buy Now | -4.76% | BMO Capital | Thanos Moschopoulos77% | $118 → $130 | Maintains | Outperform | Get Alert |
| 04/29/2025 | Buy Now | -12.09% | Argus Research | Kevin Heal64% | $150 → $120 | Maintains | Buy | Get Alert |
| 04/28/2025 | Buy Now | -12.09% | RBC Capital | Paul Treiber68% | $120 → $120 | Reiterates | Outperform → Outperform | Get Alert |
| 04/28/2025 | Buy Now | -15.75% | JP Morgan | Samik Chatterjee70% | $105 → $115 | Maintains | Overweight | Get Alert |
| 04/28/2025 | Buy Now | -7.69% | Barclays | George Wang71% | $157 → $126 | Maintains | Overweight | Get Alert |
| 04/17/2025 | Buy Now | -23.08% | JP Morgan | — | $166 → $105 | Maintains | Overweight | Get Alert |
| 04/15/2025 | Buy Now | -12.09% | CIBC | — | $150 → $120 | Maintains | Outperformer | Get Alert |
| 02/19/2025 | Buy Now | 9.89% | Stifel | Matthew Sheerin73% | $140 → $150 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | 15.02% | Barclays | George Wang71% | $139 → $157 | Maintains | Overweight | Get Alert |
| 02/05/2025 | Buy Now | 17.22% | RBC Capital | Paul Treiber68% | $140 → $160 | Maintains | Outperform | Get Alert |
| 01/31/2025 | Buy Now | 2.56% | RBC Capital | Paul Treiber68% | $115 → $140 | Maintains | Outperform | Get Alert |
| 01/30/2025 | Buy Now | 1.83% | Barclays | George Wang71% | $91 → $139 | Maintains | Overweight | Get Alert |
| 01/28/2025 | Buy Now | -21.61% | TD Securities | Daniel Chan79% | $70 → $107 | Maintains | Buy | Get Alert |
| 01/08/2025 | Buy Now | -15.75% | RBC Capital | Paul Treiber68% | $75 → $115 | Maintains | Outperform | Get Alert |
| 12/10/2024 | Buy Now | -26.74% | Stifel | Matthew Sheerin73% | $70 → $100 | Maintains | Buy | Get Alert |
| 11/22/2024 | Buy Now | -30.4% | UBS | David Vogt67% | → $95 | Initiates | → Neutral | Get Alert |
| 11/05/2024 | Buy Now | -33.33% | Barclays | George Wang71% | → $91 | Initiates | → Overweight | Get Alert |
| 10/24/2024 | Buy Now | -48.72% | TD Cowen | Daniel Chan79% | $68 → $70 | Maintains | Buy | Get Alert |
| 10/24/2024 | Buy Now | -48.72% | Stifel | Matthew Sheerin73% | $58 → $70 | Maintains | Buy | Get Alert |
| 10/24/2024 | Buy Now | -45.05% | RBC Capital | Paul Treiber68% | $65 → $75 | Maintains | Outperform | Get Alert |
| 10/24/2024 | Buy Now | -47.25% | BMO Capital | Thanos Moschopoulos77% | $64 → $72 | Maintains | Outperform | Get Alert |
| 10/09/2024 | Buy Now | -50.18% | TD Securities | Daniel Chan79% | $61 → $68 | Maintains | Buy | Get Alert |
| 09/09/2024 | Buy Now | -57.51% | Stifel | Matthew Sheerin73% | $58 → $58 | Upgrade | Hold → Buy | Get Alert |
| 07/26/2024 | Buy Now | -57.51% | Stifel | Matthew Sheerin73% | $51 → $58 | Maintains | Hold | Get Alert |
| 07/26/2024 | Buy Now | -56.04% | CIBC | — | $58 → $60 | Maintains | Neutral | Get Alert |
| 07/26/2024 | Buy Now | -48.72% | Canaccord Genuity | Robert Young35% | $53 → $70 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | -52.38% | RBC Capital | Paul Treiber68% | $63 → $65 | Maintains | Outperform | Get Alert |
| 06/17/2024 | Buy Now | -53.85% | BMO Capital | Thanos Moschopoulos77% | $53 → $63 | Maintains | Outperform | Get Alert |
| 05/13/2024 | Buy Now | -62.64% | Stifel | Matthew Sheerin73% | $48 → $51 | Maintains | Hold | Get Alert |
| 04/26/2024 | Buy Now | -61.17% | RBC Capital | Maxim Matushansky81% | $47 → $53 | Maintains | Outperform | Get Alert |
| 04/26/2024 | Buy Now | -64.84% | Stifel | Matthew Sheerin73% | $36 → $48 | Maintains | Hold | Get Alert |
| 04/26/2024 | Buy Now | -64.1% | CIBC | — | $41 → $49 | Downgrade | Outperform → Neutral | Get Alert |
| 04/22/2024 | Buy Now | -64.84% | BMO Capital | Thanos Moschopoulos77% | $37 → $48 | Maintains | Outperform | Get Alert |
| 03/11/2024 | Buy Now | -58.97% | Cormark Securities | Jesse Pytlak75% | → $56 | Initiates | → Buy | Get Alert |
| 01/31/2024 | Buy Now | -72.16% | RBC Capital | Maxim Matushansky81% | $33 → $38 | Maintains | Outperform | Get Alert |
| 01/31/2024 | Buy Now | -72.89% | BMO Capital | Thanos Moschopoulos77% | $32 → $37 | Maintains | Outperform | Get Alert |
| 11/30/2023 | Buy Now | -78.02% | Stifel | Matthew Sheerin73% | $26 → $30 | Maintains | Hold | Get Alert |
| 11/30/2023 | Buy Now | -76.56% | BMO Capital | Thanos Moschopoulos77% | $27 → $32 | Maintains | Outperform | Get Alert |
| 11/30/2023 | Buy Now | -75.82% | RBC Capital | Maxim Matushansky81% | $30 → $33 | Maintains | Outperform | Get Alert |
| 10/05/2023 | Buy Now | -78.75% | TD Securities | Daniel Chan79% | $23 → $29 | Maintains | Buy | Get Alert |
| 10/05/2023 | Buy Now | -78.02% | RBC Capital | Maxim Matushansky81% | $22 → $30 | Maintains | Outperform | Get Alert |
| 09/12/2023 | Buy Now | -83.88% | RBC Capital | Maxim Matushansky81% | → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 08/16/2023 | Buy Now | -82.42% | Stifel | Matthew Sheerin73% | $20 → $24 | Maintains | Hold | Get Alert |
| 07/28/2023 | Buy Now | -85.35% | Stifel | Matthew Sheerin73% | $14 → $20 | Maintains | Hold | Get Alert |
| 07/28/2023 | Buy Now | -83.15% | TD Cowen | Daniel Chan79% | $14.5 → $23 | Upgrade | Hold → Buy | Get Alert |
| 07/28/2023 | Buy Now | -82.42% | Canaccord Genuity | Robert Young35% | $16 → $24 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | -83.88% | RBC Capital | Maxim Matushansky81% | $14 → $22 | Upgrade | Sector Perform → Outperform | Get Alert |
| 05/26/2023 | Buy Now | -89.74% | RBC Capital | Maxim Matushansky81% | → $14 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 04/28/2023 | Buy Now | -89.74% | RBC Capital | Maxim Matushansky81% | $15 → $14 | Maintains | Sector Perform | Get Alert |
| 04/28/2023 | Buy Now | -89.38% | BMO Capital | Thanos Moschopoulos77% | $15.5 → $14.5 | Maintains | Outperform | Get Alert |
| 04/13/2023 | Buy Now | -89.01% | RBC Capital | Maxim Matushansky81% | → $15 | Reiterates | → Sector Perform | Get Alert |
| 02/23/2023 | Buy Now | -89.01% | RBC Capital | Paul Treiber68% | → $15 | Reiterates | → Sector Perform | Get Alert |
| 01/27/2023 | Buy Now | -89.74% | Citigroup | Jim Suva69% | $12 → $14 | Maintains | Neutral | Get Alert |
| 01/27/2023 | Buy Now | -88.64% | BMO Capital | Thanos Moschopoulos77% | $14 → $15.5 | Maintains | Outperform | Get Alert |
| 10/26/2022 | Buy Now | -91.21% | Citigroup | Jim Suva69% | $10 → $12 | Maintains | Neutral | Get Alert |
| 10/26/2022 | Buy Now | -91.21% | RBC Capital | Paul Treiber68% | $11 → $12 | Maintains | Sector Perform | Get Alert |
| 08/18/2022 | Buy Now | -89.74% | Argus Research | Kristina Ruggeri46% | → $14 | Upgrade | Hold → Buy | Get Alert |
| 07/27/2022 | Buy Now | -90.84% | BMO Capital | Thanos Moschopoulos77% | $13 → $12.5 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/27/2022 | Buy Now | -92.67% | Citigroup | Jim Suva69% | → $10 | Upgrade | Sell → Neutral | Get Alert |
FAQ
What is the target price for Celestica (CLS) stock?
The latest price target for Celestica (NYSE:CLS) was reported by Barclays on June 11, 2025. The analyst firm set a price target for $146.00 expecting CLS to rise to within 12 months (a possible 6.96% upside). 28 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Celestica (CLS)?
The latest analyst rating for Celestica (NYSE:CLS) was provided by Barclays, and Celestica maintained their overweight rating.
When was the last upgrade for Celestica (CLS)?
The last upgrade for Celestica Inc happened on September 9, 2024 when Stifel raised their price target to $58. Stifel previously had a hold for Celestica Inc.
When was the last downgrade for Celestica (CLS)?
The last downgrade for Celestica Inc happened on April 26, 2024 when CIBC changed their price target from $41 to $49 for Celestica Inc.
When is the next analyst rating going to be posted or updated for Celestica (CLS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Celestica, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Celestica was filed on June 11, 2025 so you should expect the next rating to be made available sometime around June 11, 2026.
Is the Analyst Rating Celestica (CLS) correct?
While ratings are subjective and will change, the latest Celestica (CLS) rating was a maintained with a price target of $126.00 to $146.00. The current price Celestica (CLS) is trading at is $136.50, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
